HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pamela Maffioli Selected Research

Resistin

5/2015Prevalence and associations of erectile dysfunction in a sample of Italian males with type 2 diabetes.
7/2014Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
8/2013Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
1/2013Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metformin.
12/2012Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled study.
7/2011Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study.
1/2011Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients.
8/2010Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients.
6/2010Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
1/2010Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Pamela Maffioli Research Topics

Disease

35Insulin Resistance
10/2015 - 05/2008
31Body Weight (Weight, Body)
02/2015 - 01/2009
19Type 2 Diabetes Mellitus (MODY)
11/2015 - 11/2008
11Hypertension (High Blood Pressure)
10/2015 - 03/2010
11Inflammation
02/2014 - 03/2010
4Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2015 - 06/2010
4Atherosclerosis
11/2012 - 09/2011
3Hypoglycemia (Reactive Hypoglycemia)
10/2015 - 06/2010
3Overweight
03/2013 - 05/2008
3Dyslipidemias (Dyslipidemia)
11/2012 - 01/2009
2Diabetes Complications
05/2014 - 06/2012
2Hyperglycemia
11/2012 - 06/2012
2Obesity
06/2012 - 05/2012
2Weight Loss (Weight Reduction)
05/2012 - 09/2011
2Edema
11/2011 - 06/2011
1Flatulence
11/2015
1Hyperlipidemias (Hyperlipidemia)
07/2014
1Cardiovascular Diseases (Cardiovascular Disease)
04/2013
1Hypercholesterolemia
08/2012
1Atrial Fibrillation
06/2012
1Metabolic Diseases (Metabolic Disease)
06/2012

Drug/Important Bio-Agent (IBA)

33Insulin (Novolin)FDA Link
10/2015 - 05/2008
23Glucose (Dextrose)FDA LinkGeneric
11/2015 - 12/2009
18Metformin (Glucophage)FDA LinkGeneric
11/2015 - 05/2008
16C-Reactive ProteinIBA
02/2014 - 01/2010
14ResistinIBA
05/2015 - 05/2008
13Hemoglobins (Hemoglobin)IBA
04/2015 - 01/2010
12AdiponectinIBA
05/2015 - 05/2008
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2013 - 05/2008
10Vitamin A (Retinol)FDA LinkGeneric
05/2015 - 01/2010
10Amlodipine (Norvasc)FDA LinkGeneric
01/2015 - 06/2010
8Nicotinamide PhosphoribosyltransferaseIBA
05/2015 - 01/2010
8Hypoglycemic Agents (Hypoglycemics)IBA
04/2014 - 08/2009
7AcarboseFDA LinkGeneric
11/2015 - 03/2009
7sitagliptin (Januvia)FDA Link
10/2015 - 06/2010
7Biological Markers (Surrogate Marker)IBA
01/2015 - 03/2010
7Glucagon (Glukagon)FDA Link
07/2014 - 06/2012
7HDL CholesterolIBA
04/2014 - 01/2010
7pioglitazone (Actos)FDA Link
09/2013 - 11/2008
6ProinsulinIBA
07/2014 - 06/2010
6LDL CholesterolIBA
04/2014 - 01/2010
6CholesterolIBA
04/2014 - 01/2010
6Triglycerides (Triacylglycerol)IBA
04/2014 - 01/2010
5vildagliptinIBA
11/2015 - 06/2012
5sibutramine (Meridia)FDA Link
05/2012 - 11/2008
4olmesartanIBA
01/2014 - 04/2012
4C-PeptideIBA
08/2013 - 06/2012
4orlistat (Xenical)FDA Link
05/2012 - 01/2010
4Carnitine (L-Carnitine)FDA LinkGeneric
10/2011 - 01/2010
4LeptinIBA
10/2011 - 05/2008
3Calcium Channels (Calcium Channel)IBA
02/2014 - 06/2011
3Interleukin-6 (Interleukin 6)IBA
11/2012 - 03/2010
3telmisartan (Micardis)FDA Link
06/2012 - 11/2011
3ThiazolidinedionesIBA
06/2012 - 11/2008
2AdipokinesIBA
10/2015 - 12/2012
2HormonesIBA
05/2015 - 05/2012
2AldosteroneIBA
02/2015 - 11/2013
2Metalloproteases (Metalloproteinases)IBA
02/2015 - 11/2012
2Brain Natriuretic Peptide (Natrecor)FDA Link
02/2015 - 11/2013
2glimepiride (Amarel)FDA LinkGeneric
07/2014 - 09/2011
2Glyburide (Glibenclamide)FDA LinkGeneric
09/2013 - 03/2013
2InterleukinsIBA
09/2013 - 01/2013
2BerberineIBA
04/2013 - 08/2012
2aliskirenFDA Link
03/2013 - 06/2011
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
11/2012 - 01/2011
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2012 - 01/2011
2Hydrochlorothiazide (Esidrix)FDA LinkGeneric
06/2012 - 04/2012
2valsartan (Vals)FDA Link
06/2012 - 04/2012
2exenatide (Byetta)FDA Link
05/2012 - 09/2011
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2011 - 01/2009
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2011 - 01/2009
2rosiglitazone (Avandia)FDA Link
06/2010 - 05/2008
1TabletsIBA
04/2015
1Peroxidase (Myeloperoxidase)IBA
02/2015
1PotassiumIBA
02/2015
1CreatinineIBA
02/2015
1Lipoprotein(a)IBA
02/2015
1mepirodipine (barnidipine)IBA
01/2015
1lercanidipineIBA
01/2015
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2015
1albiglutideIBA
09/2014
1First StepIBA
05/2014
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2014
1CalciumIBA
02/2014
1AngiotensinsIBA
02/2014
1CanrenoneIBA
11/2013
1vogliboseIBA
11/2012
1miglitol (Glyset)FDA Link
11/2012
1GlucosidasesIBA
11/2012
1Lipoproteins (Lipoprotein)IBA
11/2012
1Eicosapentaenoic AcidIBA
11/2012
1glucagon-like peptide receptor (receptor, glucagon-like peptide)IBA
08/2012
1LipidsIBA
06/2012
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
06/2012
1CarbohydratesIBA
06/2012
1Ramipril (Altace)FDA LinkGeneric
06/2012
1GhrelinIBA
05/2012
1OxyntomodulinIBA
05/2012
1Glucagon-Like Peptide 1 (GLP 1)IBA
05/2012

Therapy/Procedure

1Drug Therapy (Chemotherapy)
05/2012